Crohn-betegség: vizsgálatok itt: Dánia
22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
- Where
- Herlev, Odense C
- Életkor
- 18 év and over
- People
- 567 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2024-518296-56-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Where
- Herlev, Odense C
- Életkor
- 16 év to 80 év
- People
- 1200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00 - 4. fázisCsak meghívásosMOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
- Where
- Aalborg, Esbjerg, Hvidovre, Nyborg, Odense C, Vejle
- Életkor
- 18 év and over
- People
- 166
- Run by
- Odense University Hospital
See details and how to joinNCT06788340 · EU 2024-517123-39-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Aarhus, Copenhagen, Gistrup, Odense, Vejle
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 3. fázisTaking peopleA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Aarhus C, Esbjerg, Gistrup, Herlev, Hilleroed, Hvidovre, København NV, Odense C
- Életkor
- 18 év and over
- People
- 530 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07499232 - 2. fázisTaking peopleA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Where
- Esbjerg, Gistrup, Hilleroed, Hvidovre, Koege, Odense C
- Életkor
- 18 év to 75 év
- People
- 268 worldwide
- Run by
- Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00 - 4. fázisTaking peopleA study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
- Where
- Aarhus N, Slagelse
- People
- 16 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522362-78-00 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Herlev
- Életkor
- 16 év to 80 év
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00 - 2. fázisTaking peopleA clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
- Where
- Aarhus N, Copenhagen Nv, Copenhagen Oe, Herlev, Odense C
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Agomab Spain S.L.U.
See details and how to join2026-525197-19-00 - 3. fázisTaking peopleA Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Hvidovre
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00 - 2. fázisTaking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Where
- Aarhus N, Copenhagen Nv, Odense C
- Életkor
- 18 év to 75 év
- People
- 590 worldwide
- Run by
- AbbVie
See details and how to joinNCT06548542 · EU 2024-513009-30-00 - No phaseTaking peopleFeasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
- Where
- Esbjerg, Odense C, Svendborg, Vejle
- Életkor
- 18 év to 40 év
- People
- 165 worldwide
- Run by
- Esbjerg Hospital - University Hospital of Southern Denmark
See details and how to joinNCT06882993 - 3. fázisTaking peopleCrohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
- Where
- Aalborg, Aarhus N, Copenhagen Nv, Copenhagen Oe, Esbjerg, Herlev, Hilleroed, Hvidovre, Odense C
- Életkor
- 18 év and over
- People
- 302 worldwide
- Run by
- Janssen Cilag International
See details and how to join2025-521590-13-00 - 3. fázisTaking peopleA Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Where
- Hvidovre
- Életkor
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00 - 3. fázisTaking peopleA Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Where
- Copenhagen Oe, Gistrup, Hvidovre
- Életkor
- 18 év to 65 év
- People
- 396 worldwide
- Run by
- Takeda
See details and how to joinNCT06227910 · EU 2023-509391-42-00 - 2. fázisTaking peopleA Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Where
- Aalborg, Esbjerg, Hilleroed, Hvidovre, Koege, Odense C
- Életkor
- 18 év to 75 év
- People
- 192 worldwide
- Run by
- Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00 - 4. fázisTaking peopleVECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Where
- Aarhus N, Copenhagen Nv, Herlev, Hilleroed, Hvidovre, Koege, Randers Noe
- Életkor
- 18 év to 80 év
- People
- 304 worldwide
- Run by
- Alimentiv Inc.
See details and how to joinNCT06257706 · EU 2023-509096-16-00 - No phaseTaking peopleExtended Mesenteric Resection in Ileocecal Crohn's Disease.
- Where
- Odense
- Életkor
- 18 év and over
- People
- 204
- Run by
- Odense University Hospital
See details and how to joinNCT06324838 - No phaseTaking peopleMagnesium in Gastrointestinal Disease
- Where
- Aarhus N
- Életkor
- 18 év and over
- People
- 120
- Run by
- University of Aarhus
See details and how to joinNCT07338565 - 2. fázisTaking peopleSafety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
- Where
- Odense
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Odense University Hospital
See details and how to joinNCT04924270 - No phaseNot yet taking people in DániaOPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity
- Where
- Hvidovre
- Életkor
- 18 év and over
- People
- 40
- Run by
- Andreas Munk Petersen
See details and how to joinNCT07240181 - No phaseNot yet taking people in DániaPost Operative Hospital at Home After Colorectal Surgery
- Where
- Hillerød
- Életkor
- 18 év and over
- People
- 20
- Run by
- Nordsjaellands Hospital
See details and how to joinNCT07113717